Related Experiment Videos
Immunoapheresis in paraneoplastic pemphigus
H Schoen1, D Foedinger, K Derfler
1Department of Dermatology, University of Vienna Medical School, Vienna General Hospital, Austria. beatrice.volc@akh-wien.ac.at
Archives of Dermatology
|June 30, 1998
Summary
Paraneoplastic pemphigus, a rare autoimmune disorder, can be effectively treated with immunoapheresis. This therapy removes autoantibodies, leading to patient recovery when other treatments fail.
Area of Science:
- Autoimmune blistering diseases
- Dermatology
- Oncology
Background:
- Paraneoplastic pemphigus (PNP) is characterized by mucocutaneous erosions, autoantibodies, and underlying malignancy.
- Typically affects middle-aged individuals with poor response to immunosuppression.
Observation:
- A 16-year-old boy presented with severe oral erosions, halitosis, and weight loss.
- Diagnosis of PNP confirmed by histopathology, immunofluorescence, and biochemical analyses, linked to an inflammatory myofibroblastic tumor.
- Corticosteroids and tumor excision yielded minimal improvement.
Findings:
- Immunoapheresis using anti-human-IgG beads successfully removed circulating autoantibodies.
- The patient achieved complete recovery following immunoapheresis treatment.
Implications:
- Immunoapheresis offers a promising therapeutic strategy for refractory paraneoplastic pemphigus.
- This approach may improve outcomes for patients unresponsive to conventional therapies.